A potential new vaccine for COVID-19.  The European Commission approved the contract with Valneva

The agreement approved today allows for the vaccine to be adapted to new variants. Our wide range of vaccines will help us In the fight against Covid disease and its variants in Europe and abroad. The epidemic is not over yet. Anyone can get vaccinated – commented the President of the European Commission Ursula von der Leyen.

So far, the European Commission has concluded contracts with companies to produce vaccines in Europe AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNtech-Pfizer, CureVac, Moderna i Novavax.

Valniva is a French biotechnology company that is developing an inactivated virus vaccine, which is produced from live virus by chemical inhibition.

“It is a traditional vaccination technology that has been used for 60-70 years, with established methodology and a high level of safety. Most influenza vaccines and many primary vaccines use this technology. It is currently the only potential inactivated vaccine in clinical trials against Covid-19 in Europe”- The European Commission announced in a press release.


Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

A house with these walls will delight you. Scientists have developed bricks with unique properties

Will the greenhouse make sense? Thanks to the unique brick, it will…

The first exoplanet identified by the new method. It orbits around the red dwarf and is not far from Earth

The IRD infrared spectrometer installed on the Subaru telescope enabled the detection…

Smart article has been created. Just crush it to do the math

Scientists associated with Penn State and the US Air Force have designed…

Variation coefficient. This is what it is and where it applies

The coefficient of variation is worth using, among others because of its…